NCT05179915

Brief Summary

This study was conducted to determine the effect of sacral region-focused therapeutic touch applied during the latent phase of labour on hormone levels, labour comfort, and perception. A randomized sham controlled trial design was used in the study, which was conducted with 50 primiparous pregnant women. While Therapeutic Touch (25) focused on sacral region was applied in the intervention group, Sham Therapeutic Touch (25) was applied in the control group. Data were collected using a Personal Information Form, the Visual Analogue Scale, a Hormone Values Follow-up Form, the Childbirth Comfort Questionnaire and the Perception of Birth Scale. Keywords: Labor Pain,Therapeutic Touch, Childbirth, Hormones

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 6, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

August 23, 2024

Status Verified

February 1, 2024

Enrollment Period

1.1 years

First QC Date

December 17, 2021

Last Update Submit

August 20, 2024

Conditions

Keywords

Labor PainTherapeutic TouchChildbirthHormones

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS)

    VAS is a one-dimensional scale that objectively assesses pregnant woman's perception of pain. VAS is a 100 mm scale (10-cm) that represents lack of pain (0=no pain) on one end and worst possible pain (10=severe pain) on the other end; the scale is used to determine the severity of pain quantitatively. The patient marks any point between the two ends that describe his/her pain severity. The point between lack of pain and the point indicated by the patient is measured using a ruler and recorded as cm. These numeric values indicate the pregnant woman's pain severity.

    VAS were evaluated after application 30 minutes in each groups.

Secondary Outcomes (1)

  • The Perception of Birth Scale (PBS)

    PBS were evaluated after delivery in each groups.

Other Outcomes (2)

  • The Childbirth Comfort Questionnaire (CCQ)

    CCQ were evaluated after application 30 minutes in each groups.

  • Hormones

    a maternal saliva sample for hormones was took pretest and posttest (after application in 30 minutes).

Study Arms (2)

Experimental Group

EXPERIMENTAL

The experimental group will be administered 15-minute therapeutic touch focused on sacral region the latent phase and after it finishes, the participating pregnant woman will be asked to rest for 30 minutes.

Other: Therapeutic Touch focused on sacral region

Placebo Group

PLACEBO COMPARATOR

After the mimic (sham) therapeutic touch focused on sacral region , the pregnant woman will be asked to rest for 30 minutes.

Other: Therapeutic Touch focused on sacral region

Interventions

In the latent phase of labor, the field energy of the sacral region will be cleared for an average of 15 minutes.

Also known as: Placebo Touch (Mimic Touch) focused on sacral region
Experimental GroupPlacebo Group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnancy
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being primipara,
  • Having a gestational age of 38-42 weeks,
  • Planning to have a normal vaginal delivery,
  • Having a 3-4 cm dilation in the latent phase,
  • Having a single fetus and head presentation,
  • Speaking and communicating in Turkish,
  • Agreeing to participate in the study,
  • Having no high-risk pregnancy.

You may not qualify if:

  • Receiving induction,
  • Receiving labor analgesia/anesthesia,
  • Having sensitivity or problems with touch,
  • Having to leave during the intervention due to some reasons such as medical procedures, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, Sarıcam, 01330, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ebru Gözüyeşil, PhD. Associate Professor,

    Cukurova University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
In addition to ensuring the blinding of the participants in the study, blinding was also performed during the data collection, hormone values analysis, statistics and reporting stages. Women who agreed to participate in the study were not informed about the group they were assigned to. Since the participants did not know to which group they were assigned, the study was conducted in a single-blind design.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized sham controlled trial design was used in the study, which was conducted with 50 primiparous pregnant women. While Therapeutic Touch (25) focused on sacral region was applied in the intervention group, Sham Therapeutic Touch (25) was applied in the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Prof.

Study Record Dates

First Submitted

December 17, 2021

First Posted

January 6, 2022

Study Start

March 8, 2022

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

August 23, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations